Exposure-Response Relationship for Ombitasvir and Paritaprevir/Ritonavir in Hepatitis C Virus Subgenotype 1b-Infected Japanese Patients in the Phase 3 Randomized GIFT-I Study.

Gopalakrishnan, Sathej

Exposure-Response Relationship for Ombitasvir and Paritaprevir/Ritonavir in Hepatitis C Virus Subgenotype 1b-Infected Japanese Patients in the Phase 3 Randomized GIFT-I Study. [electronic resource] - Advances in therapy 04 2016 - 670-83 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

1865-8652

10.1007/s12325-016-0320-y doi


Adult
Aged
Anilides--administration & dosage
Antiviral Agents--administration & dosage
Carbamates--administration & dosage
Cyclopropanes
Double-Blind Method
Drug Monitoring--methods
Drug Therapy, Combination--methods
Female
Genes, Viral
Hepacivirus--drug effects
Hepatitis C, Chronic--drug therapy
Humans
Japan--epidemiology
Lactams, Macrocyclic
Macrocyclic Compounds--administration & dosage
Male
Middle Aged
Proline--analogs & derivatives
Ritonavir--administration & dosage
Sulfonamides
Treatment Outcome
Valine